Insider Trades of KIRK RANDAL J
Click on the column header to resort 'ascending (^) or descending (v).
Individual Insider Trades
| Company | Relation | Last Date |
Tran | OwnerType | Shares Traded | Last Price | Shares Held |
|---|---|---|---|---|---|---|---|
| ZIOPHARM ONCOLOGY INC | Director | 08/05/2011 | Buy | indirect | 116,112 | 4.65 | 116,112 |
| ZIOPHARM ONCOLOGY INC | Director | 08/08/2011 | Buy | indirect | 444,892 | 4.58 | 561,004 |
| ZIOPHARM ONCOLOGY INC | Director | 08/09/2011 | Buy | indirect | 285,518 | 5.13 | 846,522 |
| HALOZYME THERAPEUTICS INC | Director | 08/09/2011 | Buy | indirect | 738,331 | 5.88 | 738,331 |
| HALOZYME THERAPEUTICS INC | Director | 08/10/2011 | Buy | indirect | 261,669 | 6.13 | 1,000,000 |
| ZIOPHARM ONCOLOGY INC | Director | 08/18/2011 | Buy | indirect | 153,478 | 4.95 | 1,000,000 |
| ZIOPHARM ONCOLOGY INC | Director | 08/19/2011 | Buy | indirect | 197,376 | 4.91 | 1,197,376 |
| ZIOPHARM ONCOLOGY INC | Director | 08/22/2011 | Buy | indirect | 110,792 | 4.91 | 1,308,168 |
| ZIOPHARM ONCOLOGY INC | Director | 08/23/2011 | Buy | indirect | 38,294 | 4.99 | 1,346,462 |
| TRANSGENOMIC INC | Beneficial Owner (10%) | 11/08/2011 | Acquisition (Non Open Market) | indirect | 245,903 | 1.22 | 98,361 |
| HALOZYME THERAPEUTICS INC | Director | 11/14/2011 | Buy | indirect | 220,000 | 8.13 | 1,220,000 |
| HALOZYME THERAPEUTICS INC | Director | 11/15/2011 | Buy | indirect | 242,704 | 8.18 | 1,462,704 |
| HALOZYME THERAPEUTICS INC | Director | 11/16/2011 | Buy | indirect | 175,520 | 8.19 | 1,638,224 |
| HALOZYME THERAPEUTICS INC | Director | 11/21/2011 | Buy | indirect | 56,477 | 8.04 | 1,694,701 |
| HALOZYME THERAPEUTICS INC | Director | 11/22/2011 | Buy | indirect | 55,146 | 8.11 | 1,749,847 |
| HALOZYME THERAPEUTICS INC | Director | 11/23/2011 | Buy | indirect | 166,100 | 8 | 1,915,947 |
| ZIOPHARM ONCOLOGY INC | Director | 12/30/2011 | Acquisition (Non Open Market) | direct | 17,577 | 0 | 42,577 |
| ZIOPHARM ONCOLOGY INC | Director | 01/20/2012 | Buy | indirect | 1,923,075 | 5.2 | 9,896,236 |
| TRANSGENOMIC INC | Beneficial Owner (10%) | 02/03/2012 | Acquisition (Non Open Market) | indirect | 3,000,000 | 0 | 1,298,361 |
| HALOZYME THERAPEUTICS INC | Director | 02/10/2012 | Buy | indirect | 1,360,000 | 10.61 | 2,905,947 |
Latest News Headlines
IIJ Announces Partial Amendment of its Articles of Incorporation 11:10PM ET - GlobeNewswire
IIJ Announces New Management Structure 11:10PM ET - GlobeNewswire
Caterpillar, Steelworkers Union to Meet Next Week 9:55PM ET - Dow Jones Business News
Rio Tinto Begins Cutting Jobs at Utah Copper Mine After Slide 8:59PM ET - Dow Jones Business News
UPDATE: Mini Flash-Crash Trades Wiped From Tape, But Not Cancelled 8:27PM ET - Dow Jones Business News
View All